Cargando…

Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma

Detalles Bibliográficos
Autores principales:	Zhang, Ao, Zhong, Guanqing, Wang, Luocan, Cai, Rongzeng, Han, Runkun, Xu, Caixia, Chen, Shulin, Sun, Peng, Chen, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641160/ https://www.ncbi.nlm.nih.gov/pubmed/34856989 http://dx.doi.org/10.1186/s12935-021-02369-x

Ejemplares similares

Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
por: Zhang, Ao, et al.
Publicado: (2021)

Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma
por: Wu, Xiaobin, et al.
Publicado: (2021)

Correction: Dynamic metrics-based biomarkers to predict responders to anti-PD-1 immunotherapy
por: Liu, Can, et al.
Publicado: (2019)

Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
por: Ren, Daixi, et al.
Publicado: (2020)

Correction To: Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer
por: Gao, Yaohui, et al.
Publicado: (2021)

Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study
por: García-Corbacho, Javier, et al.
Publicado: (2023)

Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage
por: Li, Linfang, et al.
Publicado: (2021)

Correction to: Efficacy of single-site radiotherapy plus PD-1 inhibitors vs PD-1 inhibitors for oligometastatic non-small cell lung cancer
por: Wang, Peiliang, et al.
Publicado: (2021)

Author Correction: The efficacy and toxicities of intensive induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with N(3) disease
por: Zhang, Yingying, et al.
Publicado: (2017)

Correction: Ultrasound combined with nanobubbles promotes systemic anticancer immunity and augments anti-PD1 efficacy
Publicado: (2022)

Correction to: Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression
por: Liu, Zhikui, et al.
Publicado: (2022)

Correction to: Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing
por: Wang, Fan, et al.
Publicado: (2022)

Publisher Correction: NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells
por: Zhu, Lingqun, et al.
Publicado: (2019)

Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
por: Rice, Lisa M., et al.
Publicado: (2022)

Correction to: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
por: Chen, Hao, et al.
Publicado: (2021)

Correction: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
por: Chen, Hao, et al.
Publicado: (2023)

Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
por: Ling, Feng, et al.
Publicado: (2023)

Correction: The Diagnostic Accuracy of Ultrasonography versus Endoscopy for Primary Nasopharyngeal Carcinoma
Publicado: (2014)

Correction to: BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
por: Zhong, Mengjun, et al.
Publicado: (2022)

Dynamic Ghrelin and GH serum levels during combined simultaneous arginine clonidine stimulation test in children with dwarfism
por: Zhou, Guangzhong, et al.
Publicado: (2019)

Correction to: Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
por: Bai, Ju, et al.
Publicado: (2020)

Correction: BMI1, Stem Cell Factor Acting as Novel Serum-biomarker for Caucasian and African-American Prostate Cancer
por: Siddique, Hifzur Rahman, et al.
Publicado: (2013)

Correction: Serum microRNA Biomarkers for Detection of Non-Small Cell Lung Cancer
por: Hennessey, Patrick T., et al.
Publicado: (2012)

Correction to: Serum DNA integrity index as a potential molecular biomarker in endometrial cancer
por: Vizza, Enrico, et al.
Publicado: (2018)

Correction: PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma
por: Wang, Meng-Yao, et al.
Publicado: (2021)

Correction: PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma
por: Wang, Meng-Yao, et al.
Publicado: (2023)

Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1
Publicado: (2023)

Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
por: Kang, Yuanbo, et al.
Publicado: (2020)

Correction to: Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase
por: Liu, Jingxian, et al.
Publicado: (2021)

Correction to: Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis
por: Fan, Mengkang, et al.
Publicado: (2019)

Author Correction: Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
por: Li, Maohua, et al.
Publicado: (2022)

Correction to: Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
por: Wang, Dan, et al.
Publicado: (2021)

Correction to ‘Landscape dynamic network biomarker analysis reveals the tipping point of transcriptome reprogramming to prevent skin photodamage’
por: Zhang, Chengming, et al.
Publicado: (2022)

Author Correction: Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients
por: Wang, Youhong, et al.
Publicado: (2017)

Correction: Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents
Publicado: (2023)

Correction: Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
por: Chu, Xianjing, et al.
Publicado: (2023)

Correction: iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer
por: Rehman, Ishtiaq, et al.
Publicado: (2012)

Correction: A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
por: Wang, Mengjun, et al.
Publicado: (2013)

Correction: Detection of a Serum Siderophore by LC-MS/ MS as a Potential Biomarker of Invasive Aspergillosis
por: Carroll, Cassandra S., et al.
Publicado: (2016)

Correction to: Exploration of serum biomarkers for predicting the response to Inchinkoto (ICKT), a Japanese traditional herbal medicine
por: Uji, Masahito, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c0lnjj94aum2h4qf7ia6hnuo3u